Intas Biopharmaceuticals

The Biologics Business Unit (BU) of Intas Pharmaceuticals Limited was formerly an independent biotechnology company and was known as Intas Biopharmaceuticals Ltd. Intas Pharmaceuticals limited is an Indian company headquartered in Ahmedabad, India. The Biologics BU is located in Moraiya, Ahmedabad and is one of the leading biosimilar product manufacturers in Asia.

Intas Pharmaceuticals - Biologics Business Unit
Type
Limited
IndustryBiotechnology
Founded1984
HeadquartersAhmedabad, India
ProductsNeukine (GCSF), Erykine (EPO), Intalfa (IFN), Pegasta (Peg GCSF), Terifrac (Teriparatide), Mabtas (Rituximab), Folisurge (FSH)
Number of employees
300–350 (2013)
Websitewww.intaspharma.com

The Biologics BU of Intas Pharmaceuticals has biopharmaceutical operations with R&D facility and an EU-GMP certified bio-pharmaceutical manufacturing facility.[1]

History

Intas Biopharmaceuticals Limited was set up in 1980, by Binnish Chudgar, as an independent biotechnology division of Intas Pharmaceuticals Ltd., a mid-sized generic formulation manufacturer located in Ahmedabad, India. The BU was merged with the parent company Intas Pharmaceuticals Limited in 2013.

Corporate headquarters and production site of Intas Biopharmaceuticals Ltd.

The company faced EU-GMP (Good Manufacturing Practice) audit in December 2006, to seek approval of clinical trial of its biosimilar Filgrastim in Europe and was certified as EU-GMP compliant in April 2007, becoming the first company in India to receive such certification for biologics facility.

Apart from EU-GMP certification, the company has approvals from MCC South Africa, Gulf Cooperation Council (GCC), Syria, Yemen, Belarus and several other national health authorities for its manufacturing facility and products.

Intas Biosimilar development timeline
MabTas is Rituximab biosimilar of Intas
Intas manufactured Filgrastim registered in EU

News articles

References
  1. "Intas mfg unit gets EU-GMP certification". The Economic Times. 13 June 2007.
  2. "Intas Biopharma to market PEMETREXED in India : February 2009". prurgent.com. Retrieved 25 April 2019.
  3. "Apotex and Intas Biopharmaceuticals extend their collaborative development of biosimilars to include Peg filgrastim : January 2009". intasbiopharma.co.in. Retrieved 25 April 2019.
  4. "Intas Biopharma to Market Lung Cancer Drug GEFITINIB in India : May 2008". intasbiopharma.co.in. Retrieved 25 April 2019.
  5. "SEO - Analyse - Brukeroptimalisering - Findability AS". SEO - Analyse - Søkemotoroptimalisering - Findability. Retrieved 25 April 2019.
  6. "Paragon of success - Express Pharma". archivepharma.expressbpd.com. Retrieved 25 April 2019.
  7. "Intas Biopharma launches new Sales Divisions in India : March 2008". intasbiopharma.co.in. Retrieved 25 April 2019.
  8. "Intas Pharmaceuticals Ltd. » 1st Biosimilar Approval :: Intas - a leading global pharmaceutical formulation development, manufacturing and marketing company". www.intaspharma.com. Retrieved 25 April 2019.
  9. "Intas Pharma launches its first biosimilar product Accofil in Europe". 23 February 2015. Retrieved 25 April 2019 – via The Economic Times.
  10. Reporter, B. S. (23 February 2015). "Ahmedabad-based Intas Pharma launches biosimilar in EU". Retrieved 25 April 2019 – via Business Standard.
  11. "Business News, India Stock Market, Personal Finance, IPO, Financial News Headlines". The Financial Express. Retrieved 25 April 2019.
  12. Dandekar, Vikas; Barman, Arijit (7 October 2016). "Chudgars of Intas: A family that dreams big together". Retrieved 25 April 2019 – via The Economic Times.
  13. Dandekar, Vikas; Barman, Arijit (7 October 2016). "Chudgars of Intas: A family that dreams big together". Retrieved 25 April 2019 – via The Economic Times.
  14. "Global Interferon Alpha-2b Biosimilar Market 2019 Demand & Revenue: Pharmsandard, MSD, Intas Biopharmaceuticals, Biosidus, Sicor Biotech – Technology Market".
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.